TONON, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 7.366
EU - Europa 6.917
AS - Asia 4.799
SA - Sud America 1.450
Continente sconosciuto - Info sul continente non disponibili 333
OC - Oceania 199
AF - Africa 117
Totale 21.181
Nazione #
US - Stati Uniti d'America 6.849
RU - Federazione Russa 3.015
SG - Singapore 1.568
CN - Cina 1.465
BR - Brasile 1.201
IT - Italia 1.086
HK - Hong Kong 706
VN - Vietnam 472
SE - Svezia 459
GB - Regno Unito 420
DE - Germania 338
RO - Romania 333
CA - Canada 327
FR - Francia 303
AU - Australia 198
AT - Austria 118
AR - Argentina 112
IN - India 106
NL - Olanda 105
BD - Bangladesh 98
JP - Giappone 98
FI - Finlandia 93
PL - Polonia 83
MX - Messico 82
CH - Svizzera 76
ES - Italia 73
CZ - Repubblica Ceca 65
LT - Lituania 64
EC - Ecuador 47
ZA - Sudafrica 47
ID - Indonesia 43
TR - Turchia 41
NO - Norvegia 38
UA - Ucraina 36
IQ - Iraq 35
AL - Albania 34
DK - Danimarca 33
JM - Giamaica 27
EE - Estonia 26
BE - Belgio 25
CR - Costa Rica 25
IE - Irlanda 25
CO - Colombia 24
MA - Marocco 23
RS - Serbia 23
PK - Pakistan 20
PY - Paraguay 17
CL - Cile 16
MY - Malesia 16
VE - Venezuela 16
SA - Arabia Saudita 15
PH - Filippine 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 12
HN - Honduras 11
TN - Tunisia 11
DO - Repubblica Dominicana 10
GR - Grecia 10
NP - Nepal 10
IL - Israele 9
GT - Guatemala 8
KE - Kenya 6
TW - Taiwan 6
UY - Uruguay 6
AZ - Azerbaigian 5
BB - Barbados 5
CM - Camerun 5
EG - Egitto 5
LB - Libano 5
MD - Moldavia 5
MK - Macedonia 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
BN - Brunei Darussalam 4
BO - Bolivia 4
DZ - Algeria 4
IR - Iran 4
JO - Giordania 4
NI - Nicaragua 4
PE - Perù 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BH - Bahrain 3
CY - Cipro 3
GY - Guiana 3
HU - Ungheria 3
OM - Oman 3
PT - Portogallo 3
AO - Angola 2
BW - Botswana 2
GD - Grenada 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
NG - Nigeria 2
PA - Panama 2
PR - Porto Rico 2
SV - El Salvador 2
Totale 20.819
Città #
Dallas 1.543
Ashburn 909
Singapore 740
Hong Kong 705
Moscow 657
San Jose 586
Milan 350
Los Angeles 297
Council Bluffs 270
Shanghai 235
Hefei 232
Phoenix 214
Lauterbourg 193
London 186
Ho Chi Minh City 184
New York 180
Sydney 179
Beijing 169
Montreal 138
Princeton 137
São Paulo 137
Lawrence 136
Frankfurt am Main 119
Santa Clara 108
Hanoi 91
Nuremberg 90
Orem 78
Tokyo 78
Buffalo 75
Toronto 75
Warsaw 74
Vienna 68
Stockholm 65
Prague 64
Rome 64
Paris 61
Amsterdam 60
Helsinki 55
Zurich 49
Miano 47
Acalanes Ridge 44
Rio de Janeiro 43
Houston 38
Piscataway 37
Washington 37
Waterbury 36
Mexico City 35
Boardman 34
Brooklyn 34
Atlanta 33
Chicago 33
Copenhagen 33
Chennai 32
Madrid 32
Tirana 32
Munich 30
Charlotte 29
Oslo 29
Poplar 28
Denver 26
Lombard 26
Boston 25
Brussels 25
Guangzhou 25
Johannesburg 25
Seattle 25
Tallinn 24
Dublin 23
Turku 23
Belgrade 22
Curitiba 22
Edison 22
Haiphong 22
The Dalles 22
Guayaquil 21
North Bergen 21
Buenos Aires 19
Manchester 19
Miami 19
San José 19
Segrate 19
Bern 18
Kingston 18
Kyiv 18
Baltimore 17
Bucharest 17
Da Nang 17
Falkenstein 17
Philadelphia 17
Sao Paulo 17
Brasília 16
Fortaleza 16
Goiânia 16
Guarulhos 15
Manaus 15
Naples 15
Belo Horizonte 14
Brescia 14
Brisbane 14
Columbus 14
Totale 11.146
Nome #
The 1+Million Genomes Minimal Dataset for Cancer 4.136
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 213
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 197
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 195
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 188
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 168
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 156
Global transcriptomic changes occur in uterine fluid-derived extracellular vesicles during the endometrial window for embryo implantation 155
Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation 138
A federated learning system for precision oncology in Europe: DigiONE 133
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 130
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression 129
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches. 129
A whole-genome sequencing study associates GRAMD1B with multiple sclerosis risk and disease activity 129
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection 128
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 128
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 127
Extracellular vesicles secreted by human aneuploid embryos present a distinct transcriptomic profile and upregulate MUC1 transcription in decidualised endometrial stromal cells 123
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 118
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 116
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 114
DNA methylation alterations in prostate cancer: from diagnosis to treatment 113
Iron increases the susceptibility of multiple myeloma cells to bortezomib 113
Author Correction: Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation (Scientific Reports, (2020), 10, 1, (16906), 10.1038/s41598-020-73835-1) 112
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 111
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 107
Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma 104
A next generation sequencing study in Italian multiplex families with multiple sclerosis 104
ASSOCIATION BETWEEN RS6152 POLYMORPHISM IN THE ANDROGEN RECEPTOR GENE AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 103
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 103
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. 103
A whole-genome epigenomic approach in multiple sclerosis multiplex families revealed new epigenetic traits involved in the disease 102
UNCAN.eu: Toward a European Federated Cancer Research Data Hub 102
Analyzing genomic and epigenetic profiles in single cells by hybrid transposase (scGET-seq) 102
N-Glycosylation Inhibition Hinders Immunosuppressive Activity of Tumor Microenvironment Cells and Improves CAR T Cell Efficacy 102
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 100
Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics 100
A "static" karyotype in epithelial cancer cell lines despite ongoing chromsomal instability 99
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies 98
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 98
FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy 96
Chest CT in the emergency department for suspected COVID-19 pneumonia 96
Whole-genome epigenomic approach in multiplex families with multiple sclerosis revealed new epigenetic traits involved in the disease 95
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 95
A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands 94
Dual spatial host-bacterial gene expression in Mycobacterium abscessus respiratory infections 93
Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer 93
RNA sequencing of blood from sex- and age-matched discordant siblings supports immune and transcriptional dysregulation in autism spectrum disorder 92
A whole-exome sequencing approach in multiplex Italian multiple sclerosis families to identify new genes involved in the disease 91
ATR addiction in Multiple Myeloma: synthetic lethal approaches exploiting established therapies 91
Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment 91
An Oncogene-Regulated Epigenetic Switch in T Cell Acute Lymphoblastic Leukemia 91
IFNalpha by In Vivo-Engineered Macrophages Abates Liver Metastases and Triggers Counter Regulatory Responses Limiting Efficacy 90
A "static" karyotype in epithelial cancer cell lines despite ongoing chromosomal instability 88
A Whole-Exome Sequencing Study In Multiple Sclerosis Multiplex Families 88
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength 87
IFNalpha by in vivo-engineered macrophages abates liver metastases and triggers counter regulatory responses limiting efficacy 85
Rete IDEA: solving the unsolved diagnoses of primary immunodeficiency 85
Somatic mutations affect key pathways in lung adenocarcinoma 85
RADIOMIC AND GENOMIC APPROACHES FOR THE ENHANCED DIAGNOSIS OF RENAL CANCER (REDIRECT): A TRANSLATIONAL PILOT STUDY 84
The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation 84
Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism 84
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history 81
Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans 81
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene 80
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer 79
Cancer Organoids as reliable disease models to drive clinical development of novel therapies 79
Early tolerance and late persistence as alternative drug responses in cancer 79
Cancer Evolution: A Multifaceted Affair 79
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 78
Genomics in Multiple Myeloma: From Conventional Cytogenetics to Novel Whole-Genome Sequencing Approaches 77
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 76
Common and contrasting genomic profiles among the major human lung cancer subtypes 75
Profiling the Genomic Landscape at the Early Stages of CLL: Low Genomic Complexity and Paucity of Driver Mutations in MBL and Indolent CLL 75
Time of Origin and Environmental Drivers of Leukemia Immune Escape after Transplantation 75
CS1, a new surface target on multiple myeloma (MM) cells, protects myeloma cells from apoptosis via-regulation of ERKI/2, AKT and STAT3 signaling cascades 74
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway 73
Karyotypic complexity of the NCI-60 drug-screening panel. 73
MATRIGEL CAPILLARITY-DRIVEN FILLING IN OPEN MICROFLUIDICS FOR HIGH-THROUGHPUT DRUG SCREENING ON 3D PATIENT DERIVED ORGANOIDS CULTURES 72
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells 72
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets 72
Nizp1 is a specific NUP98-NSD1 functional interactor that regulates NUP98-NSD1-dependent oncogenic programs 71
Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus 71
Spectral karyotyping combined with locus-specific FISH simultaneously defines genes and chromosomes involved in chromosomal translocations. 71
C-jun and C-Abl in human multiple myeloma cell death 70
KDM6A regulates immune response genes in multiple myeloma 70
Identification of a truncated ADP-activated P-2X1 receptor in platelets and megakaryocytic cell lines 70
IRON CONTRIBUTES TO BORTEZOMIB SENSITIVITY IN MULTIPLE MYELOMA CELLS 69
Multiple reciprocal translocations in salivary gland mucoepidermoid carcinomas 69
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients 69
Identification of new human liver cancer genes by a novel lentiviral vector-based insertional mutagenesis approach in three mouse models of hepatocarcinogenesis 69
Genomic Instability and Replicative Stress in Multiple Myeloma: The Final Curtain? 68
Towards cross-border access to human genomes and clinical information at scale for research and healthcare 68
WNT Signaling in Hematological Malignancies 67
JunB is a key regulator of multiple myeloma bone marrow angiogenesis 67
Chromogranin A is preferentially cleaved into pro-angiogenic peptides in the bone marrow of multiple myeloma patients 67
Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features 67
Identification of alternative forms of a P2X(1) receptor in platelets and megakaryocytic cells. 67
In vitro and in vivo activity of the VEGF inhibitor pazopanib 67
Expression of apoptotic markers in activated platelets is mediated in part by cathepsin 67
Totale 13.758
Categoria #
all - tutte 101.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.393


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022155 0 0 0 12 2 0 2 120 2 11 1 5
2022/2023796 285 177 31 7 48 113 33 59 15 8 13 7
2023/2024433 10 14 47 124 30 53 15 29 1 25 23 62
2024/20256.204 248 59 88 123 112 260 739 363 504 2.696 760 252
2025/202611.057 743 941 1.603 1.439 754 415 819 724 2.719 497 214 189
2026/20272.509 287 729 589 904 0 0 0 0 0 0 0 0
Totale 21.181